Home Page
Hypertension
Heart Failure
Acute MI
Important Safety Information
Summary
Prescribing Information
Contact Us
Search This Site
References

 
 
24-HOUR BP REDUCTION WITH JUST A SINGLE DAILY DOSE
  • Significantly reduces systolic and diastolic BP regardless of age or race
    -- The antihypertensive effect is less in blacks than in Caucasians
    -- The antihypertensive effect may diminish at the end of the dosing interval
    -- Antihypertensive effects of ZESTRIL have been established in hypertensive pediatric patients aged 6 to 16 years. [ See full prescribing information]
  • The long-term prognostic significance of BP control determined by ambulatory BP monitoring has yet to be established
  • ZESTRIL is contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an angiotensin-converting enzyme inhibitor and in patients with hereditary or idiopathic angioedema
       



Patient Profiles
   

Hypertensive Patient
Hypertensive Patient with
Type II Diabetes



   
USE IN PREGNANCY
When used in pregnancy during the second and third trimesters, ACE Inhibitors can cause injury and even death to the developing fetus. When pregnancy is detected, ZESTRIL (lisinopril) should be discontinued as soon as possible. See full Prescribing Information, including WARNINGS, Fetal/Neonatal Morbidity and Mortality.

Evaluation of patients with hypertension, heart failure, or MI should always include assessment of renal function (see DOSAGE AND ADMINISTRATION).
 
 
Previous PageNext Page
 
FULL PRESCRIBING INFORMATIONSEARCH

This product information is intended for US health care professionals only.
215737  10/03  Copyright ©2003 AstraZeneca Pharmaceuticals LP.  All rights reserved.



click here to see the boxed warning